Therefore, in future research, we will apply for the inclusion of edoxaban in clinical application, then detect the expression of HBG1 and HBD in the blood of patients with atrial fibrillation before and after taking edoxaban, and obtain more sufficient clinical evidence. Here, HBG1 is linked to atrial fibrillation.